GetTopicDetailResponse(id=6f331090956f, topicName=mRNA腫瘤疫苗, introduction=mRNA腫瘤疫苗, content=PD-1 mRNA腫瘤疫苗, image=null, comments=0, allHits=1075, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Mon Dec 25 10:38:45 CST 2023, time=2023-12-25, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=484954, tagList=[TagDto(tagId=484954, tagName=mRNA腫瘤疫苗)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2177182, encodeId=931c21e7182c3, content=<a href='/topic/show?id=34b54848271' target=_blank style='color:#2F92EE;'>#帕博利珠單抗#</a> <a href='/topic/show?id=6f331090956f' target=_blank style='color:#2F92EE;'>#mRNA腫瘤疫苗#</a> <a href='/topic/show?id=e79f1091e1bd' target=_blank style='color:#2F92EE;'>#mRNA-4157#</a>, objectTitle=mRNA腫瘤疫苗聯(lián)合PD-1治療最新數(shù)據(jù)公布，復發(fā)或死亡風險降低49%！, objectType=article, longId=806836, objectId=c1648068360e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20231222/06ed19ad66f04fb59cb4d4cfeef42043.jpg, objectUrl=/article/show_article.do?id=c1648068360e, replyNumber=0, likeNumber=139, createdTime=2023-12-26, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=c1648068360e, moduleTitle=mRNA腫瘤疫苗聯(lián)合PD-1治療最新數(shù)據(jù)公布，復發(fā)或死亡風險降低49%！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c1648068360e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2177028, encodeId=ef1221e7028d7, content=<a href='/topic/show?id=234613893a4' target=_blank style='color:#2F92EE;'>#PD-1#</a> <a href='/topic/show?id=6f331090956f' target=_blank style='color:#2F92EE;'>#mRNA腫瘤疫苗#</a>, objectTitle=遠處轉移或死亡風險降低62%！mRNA腫瘤疫苗聯(lián)合PD-1治療最新數(shù)據(jù)公布，關鍵性III期隨機試驗已啟動, objectType=article, longId=805527, objectId=c1cb80552ed9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-filling-form-U2MAYRK.jpg, objectUrl=/article/show_article.do?id=c1cb80552ed9, replyNumber=0, likeNumber=117, createdTime=2023-12-25, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c1cb80552ed9, moduleTitle=遠處轉移或死亡風險降低62%！mRNA腫瘤疫苗聯(lián)合PD-1治療最新數(shù)據(jù)公布，關鍵性III期隨機試驗已啟動, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c1cb80552ed9)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2023-12-25發(fā)表于上海
